We read with interest the study by Cheung et al1 reporting that long-term use of proton pump inhibitors (PPIs) was associated with an increased risk of gastric cancer (GC) in participants after Helicobacter pylori eradication. Considering PPIs were widely used for the treatment of acid-related disorders, and previous studies about PPIs use and risk of GC did not have a consistent result. To better understand this issue, we conducted this meta-analysis that investigated the associations between long-term PPIs use and risk of GC.
We searched the PubMed, Embase and Web of Science for potential studies published before March 2018. The inclusion criteria were (1) randomised controlled trail, case–control study or cohort study; (2) defined GC and exposure to PPIs clearly; and (3) reported the relative risk (RR), ORs or other measures of association. The quality of included study was evaluated according to the Newcastle–Ottawa Scale. The pooled OR and 95% CIs were...
https://ift.tt/2Is9jU1
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.